This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Jan;6(1):22-8.

doi: 10.4103/0973-1229.33005.

Medical guidelines and performance measures: the need to keep them free of industry influence

Peter Q Eichacker¹, Charles Natanson

Affiliations

PMID: 22013347
PMCID: PMC3190551
DOI: 10.4103/0973-1229.33005

Medical guidelines and performance measures: the need to keep them free of industry influence

Peter Q Eichacker et al. Mens Sana Monogr. 2008 Jan.

. 2008 Jan;6(1):22-8.

doi: 10.4103/0973-1229.33005.

Authors

Peter Q Eichacker¹, Charles Natanson

Affiliation

¹ Critical Care Medicine Department, National Institutes of Health, Bethesda, MD.

PMID: 22013347
PMCID: PMC3190551
DOI: 10.4103/0973-1229.33005

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

None declared.

Similar articles

Current guidelines regarding industry-sponsored continuing medical education.
DelSignore JL. DelSignore JL. Clin Orthop Relat Res. 2003 Jul;(412):21-7. doi: 10.1097/01.blo.0000074411.99625.55. Clin Orthop Relat Res. 2003. PMID: 12838047 Review.
Guidelines, editors, pharma and the biological paradigm shift.
Singh AR, Singh SA. Singh AR, et al. Mens Sana Monogr. 2007 Jan;5(1):27-30. doi: 10.4103/0973-1229.32176. Mens Sana Monogr. 2007. PMID: 22058616 Free PMC article.
Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Mitchell AP, Mishra A, Dey P, Curry MA, Trivedi NU, Haddadin M, Rahman MW, Winn AN, Dusetzina SB, Bach PB. Mitchell AP, et al. Oncologist. 2021 Sep;26(9):771-778. doi: 10.1002/onco.13823. Epub 2021 May 26. Oncologist. 2021. PMID: 33982829 Free PMC article.
Awareness and enforcement of guidelines for publishing industry-sponsored medical research among publication professionals: the Global Publication Survey.
Wager E, Woolley K, Adshead V, Cairns A, Fullam J, Gonzalez J, Grant T, Tortell S. Wager E, et al. BMJ Open. 2014 Apr 19;4(4):e004780. doi: 10.1136/bmjopen-2013-004780. BMJ Open. 2014. PMID: 24747794 Free PMC article.
Is keep/refer decision making an integral part of national guidelines for the physiotherapy profession within Europe? A review.
Lackenbauer W, Janssen J, Roddam H, Selfe J. Lackenbauer W, et al. Physiotherapy. 2017 Dec;103(4):352-360. doi: 10.1016/j.physio.2016.11.005. Epub 2016 Nov 28. Physiotherapy. 2017. PMID: 28823566 Review.

See all similar articles

References

1. Baillie JK. Drotrecogin Alfa (Activated) in Severe Sepsis (Correspondence) N Engl J Med. 2006;354:95. - PubMed
1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. The Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group. N Engl J Med. 2001;344:699–709. - PubMed
1. Bero LA, Glantz S, Hong MK. The limits of competing interest disclosures. Tobacco Control. 2005;14:118–126. - PMC - PubMed
1. BioPortfolio 20007. Eli Lilly’s Xigris: struggling to overcome its problems in the sepsis market. Available from: http://www.bioportfolio.com/news/datamonitor_29.htm. [Last accessed on 2007 Apr 17]
1. Brennan TA, Rothman DJ, Blank L, Blumenthal D, Chimonas SC, Cohen JJ, et al. Health industry practices that create conflicts of interest: A policy proposal for academic medical centers. JAMA. 2006;295:429–433. - PubMed

LinkOut - more resources

Full Text Sources